Oncolytics Biotech, Inc. (ONCY)
0.8458
+0.01
(+0.91%)
USD |
NASDAQ |
Sep 01, 16:00
0.8458
0.00 (0.00%)
After-Hours: 16:32
Oncolytics Biotech Total Long Term Debt (Quarterly) : 0.31M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.31M |
| March 31, 2026 | 0.342M |
| December 31, 2025 | 0.37M |
| September 30, 2025 | 0.41M |
| June 30, 2025 | 0.449M |
| March 31, 2025 | 0.6948M |
| December 31, 2024 | 0.561M |
| September 30, 2024 | 0.7876M |
| June 30, 2024 | 0.8155M |
| March 31, 2024 | 0.8328M |
| December 31, 2023 | 0.3208M |
| September 30, 2023 | 0.3802M |
| June 30, 2023 | 0.362M |
| March 31, 2023 | 0.419M |
| December 31, 2022 | 0.2753M |
| September 30, 2022 | 0.3354M |
| June 30, 2022 | 0.405M |
| March 31, 2022 | 0.4677M |
| December 31, 2021 | 0.5184M |
| September 30, 2021 | 0.5611M |
| June 30, 2021 | 0.6013M |
| March 31, 2021 | 0.4968M |
| December 31, 2020 | 0.3156M |
| September 30, 2020 | 0.3867M |
| June 30, 2020 | 0.2388M |
| Date | Value |
|---|---|
| March 31, 2020 | 0.3072M |
| December 31, 2019 | 0.3904M |
| September 30, 2019 | 0.4563M |
| June 30, 2019 | 0.5279M |
| March 31, 2019 | 0.583M |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 1.371B |
| Sangamo Therapeutics, Inc. | 19.33M |
| Sarepta Therapeutics, Inc. | 1.046B |
| Anixa Biosciences, Inc. | 0.14M |
| Vicapsys Life Sciences, Inc. | 0.00 |